| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/20/2011 | CN102018718A Application of Xanthoceraside compound |
| 04/20/2011 | CN102018716A Medical application of protopanaxatriol and protopanaxadiol in nervous system diseases |
| 04/20/2011 | CN102018715A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 04/20/2011 | CN102018708A Pharmaceutical composition containing amlodipine and atorvastatin magnesium |
| 04/20/2011 | CN102018699A Application of Xyloketal B in preparing antiatherosclerotic medicaments |
| 04/20/2011 | CN102018695A Atenolol soft capsule and preparation method thereof |
| 04/20/2011 | CN102018691A Medicament for treating thrombotic cardiovascular and cerebrovascular diseases and application thereof |
| 04/20/2011 | CN102018685A Terazosin pellicle and preparation method thereof |
| 04/20/2011 | CN102018684A Candesartan cilexetil self-microemulsion soft capsule and preparation method thereof |
| 04/20/2011 | CN102018683A Effervescent tablet containing piracetam |
| 04/20/2011 | CN102018671A Estradiol transdermal spray and preparation method thereof |
| 04/20/2011 | CN102018662A Method for preparing dihydroergotoxine mesilate injection |
| 04/20/2011 | CN102018660A Naftopidil suppository and preparation method thereof |
| 04/20/2011 | CN102018655A Transdermal medicament delivery combined preparation |
| 04/20/2011 | CN102018403A Pillow with curing function to heart |
| 04/20/2011 | CN102018255A Self-prepared beverage for reducing blood pressure |
| 04/20/2011 | CN102018212A Red yeast rice capsules and preparation method thereof |
| 04/20/2011 | CN102018205A Formula and preparation method of home-style dish for treating hypertension |
| 04/20/2011 | CN102018040A Raw food formula for treating hypertension and preparation method thereof |
| 04/20/2011 | CN101623437B Pulse-activating preparation for injection and preparation method thereof |
| 04/20/2011 | CN101612333B Chinese medicine for treating cardiovascular and cerebrovascular disease |
| 04/20/2011 | CN101579482B Medicinal composition for treating hypertension and preparation method thereof |
| 04/20/2011 | CN101579481B Medicinal composition for treating hypertension |
| 04/20/2011 | CN101564476B Chinese medicament for treating coronary heart disease |
| 04/20/2011 | CN101560178B Polysubstituted indoline compound, preparation method and medical application thereof |
| 04/20/2011 | CN101491665B Hypertension-treating medicine |
| 04/20/2011 | CN101468072B Blood-activating Chinese medicine preparation for coronary disease |
| 04/20/2011 | CN101417971B Indolines compounds, preparation method and pharmaceutical application thereof |
| 04/20/2011 | CN101390856B Solid preparation of clopidogrel and preparation method thereof |
| 04/20/2011 | CN101362764B 5,7-diaminopyrazolo '4,3-d!pyrimidines with PDE-5 inhibiting activity |
| 04/20/2011 | CN101357177B Traditional Chinese medicine for preventing and treating central serous chorioretinopathy and preparation method thereof |
| 04/20/2011 | CN101314769B Staphylokinase and expression vector thereof |
| 04/20/2011 | CN101313902B Traditional Chinese medicine active monomer component with liver protection function and uses thereof |
| 04/20/2011 | CN101199856B Oxygen-carrying anti-shock medicament |
| 04/20/2011 | CN101195031B Gluconic acid modified chitosan nucleophilic NO donator and synthesizing method thereof |
| 04/20/2011 | CN101181476B External application medicine for curing podosoma phlebothrombosis and phlebitis as well as preparation method |
| 04/20/2011 | CN101167728B Doxazosin-mesylate controlled-releasing tablet and preparation method thereof |
| 04/20/2011 | CN101134105B Pharmaceutical composition containing recombination human pancreatic kininogenase for treating and/or preventing cerebral infarction |
| 04/20/2011 | CN101077353B Cardiac and cerebral vascular disease treating medicine |
| 04/20/2011 | CN101045089B Traditional Chinese medicine with functions of tonifying-qi, supporting-Yang, tonifying-heart and clearing-damp, and its quality control method |
| 04/19/2011 | US7928255 Intermediates for the preparation of lipoxin A4 analogs |
| 04/19/2011 | US7928130 Isoxazoline compounds having MIF antagonist activity |
| 04/19/2011 | US7928125 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928124 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928119 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 04/19/2011 | US7928096 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same |
| 04/19/2011 | US7928066 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 04/19/2011 | US7927821 Methods of screening for compounds which bind G protein-coupled receptors |
| 04/19/2011 | US7927627 Nanoparticulate fibrate formulations |
| 04/19/2011 | US7927624 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 04/19/2011 | US7927622 Methods of transnasal transport/immunization with highly adaptable carriers |
| 04/19/2011 | US7927621 Thioester-ester-amide copolymers |
| 04/19/2011 | US7927365 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
| 04/19/2011 | US7927364 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
| 04/19/2011 | CA2628963C Benzene derivative or salt thereof |
| 04/19/2011 | CA2610637C Use of agomelatine to obtain drugs intended for the treatment of periventricular leukomalacia |
| 04/19/2011 | CA2571133C Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/19/2011 | CA2539476C Quinazoline potassium channel inhibitors |
| 04/19/2011 | CA2486495C 9-alpha-substituted estratrienes as selectively active estrogens |
| 04/19/2011 | CA2476012C Substituted pyridinones as modulators of p38 map kinase |
| 04/19/2011 | CA2458452C Gnrh agonist combination drugs |
| 04/19/2011 | CA2447703C Methods for proliferating terminal differentiated cells and recombinant vectors therefor |
| 04/19/2011 | CA2445048C Preparations containing afamin for treating oxidative stress-induced neurogenerative disease |
| 04/19/2011 | CA2400886C Novel galenical form for oral administration with prolonged release of molsidomine |
| 04/19/2011 | CA2385659C Novel antiarrhythmic peptides |
| 04/19/2011 | CA2384417C Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 04/16/2011 | CA2777223A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators |
| 04/14/2011 | WO2011044229A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators |
| 04/14/2011 | WO2011043980A1 Methods and compositions related to clot-binding lipid compounds |
| 04/14/2011 | WO2011043788A2 Daptomycin for multiple sclerosis |
| 04/14/2011 | WO2011043480A1 Homocysteine synthase inhibitor |
| 04/14/2011 | WO2011043479A1 Therapeutic agent for cerebral infarction |
| 04/14/2011 | WO2011043456A1 Halogenated alkylsulfonamide derivative |
| 04/14/2011 | WO2011043453A1 Activator for peroxisome proliferator activated receptor |
| 04/14/2011 | WO2011043387A1 Pyrazoloxazole compound |
| 04/14/2011 | WO2011043381A1 Pyrazolothiazole compound |
| 04/14/2011 | WO2011043371A1 Oxazole compound |
| 04/14/2011 | WO2011042877A1 Use of celivarone for the preparation of a medicament for use in the prevention of implantable cardioverter defibrillator interventions or death |
| 04/14/2011 | WO2011042474A1 Novel estrogen receptor ligands |
| 04/14/2011 | WO2011042473A2 Novel estrogen receptor ligands |
| 04/14/2011 | WO2011042469A1 Use of a compound based on eremophilanolides |
| 04/14/2011 | WO2011042399A1 Bicyclic heterocycles and their use as ccr2 receptor antagonists |
| 04/14/2011 | WO2011042333A1 Lactobacillus plantarum strains as hypocholesterolemic agents. |
| 04/14/2011 | WO2011041872A1 Nitric oxide amino acid ester compounds for the prophylaxis of angina pectoris |
| 04/14/2011 | WO2008031501A3 2-phenoxy nicotine acid derivative and use thereof |
| 04/14/2011 | US20110086919 High eicosapentaenoic acid producing strains of yarrowia lipolytica |
| 04/14/2011 | US20110086917 Use of l-carnitine for the treatment of cardiovascular diesases |
| 04/14/2011 | US20110086899 Pharmaceutical compositions for oral administration |
| 04/14/2011 | US20110086893 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/14/2011 | US20110086892 Pre-Mixed, Ready-To-Use Pharmaceutical Compositions |
| 04/14/2011 | US20110086885 Indole-2-carboxylic acid amides |
| 04/14/2011 | US20110086882 Pyrazolothiazole compound |
| 04/14/2011 | US20110086879 Carboxamide compounds and their use as calpain inhibitors |
| 04/14/2011 | US20110086864 N-hydroxyamide derivatives and use thereof |
| 04/14/2011 | US20110086857 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 04/14/2011 | US20110086856 Compositions useful as inhibitors of protein kinases |
| 04/14/2011 | US20110086855 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 04/14/2011 | US20110086853 Therapeutic Compounds |
| 04/14/2011 | US20110086851 Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases |
| 04/14/2011 | US20110086847 Thiadiazole modulators of beta adrenergic receptor |